LXR-623

• Description:

  A clinically viable, highly brain-penetrant LXRα-partial/LXRβ-full agonist with binding Ki of 33 nM/248 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  422.7784

• Molecular Formula:

  C21H12ClF5N2

• Notes:

  Research use only, not for human use.

• Receptor:

  LXRα|LXRβ

• CAS Number:

  875787-07-8